Kairacort 6 Tablet contains Deflazacort 6mg, a synthetic glucocorticoid used for its potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, allergic disorders, and certain dermatological diseases. Deflazacort acts by modulating the immune response and inhibiting the release of inflammatory mediators, thereby reducing inflammation and tissue damage. Compared to other corticosteroids, Deflazacort is associated with a more favorable side effect profile, particularly concerning bone metabolism and glucose tolerance. Kairacort 6 is administered orally, with dosage tailored according to the severity of the condition and patient response. It is essential to adhere to prescribed dosing schedules and avoid abrupt discontinuation to prevent adrenal insufficiency. Common adverse effects may include gastrointestinal discomfort, increased susceptibility to infections, mood changes, and alterations in blood glucose levels. Caution is advised in patients with diabetes, hypertension, osteoporosis, or peptic ulcer disease. Regular monitoring by a healthcare professional is recommended to optimize therapeutic outcomes and minimize risks. Kairacort 6 should be used under strict medical supervision to ensure safe and effective treatment.